NASDAQ : VREX
Varex Imaging Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 18.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 777.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 776.79M |
| Enterprise Value | 1.06B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.15M |
| Shares Outstanding | 42.15M |
| Shares Change (YoY) | +2.55% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 87.94% |
| Float | 41.42M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 35.44 |
| Forward PE | 20.25 |
| PS Ratio | 0.90 |
| Forward PS | 0.87 |
| PB Ratio | 1.56 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 68.74 |
| PEG Ratio | 2.25 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 47.78 |
| EV / Sales | 1.22 |
| EV / EBITDA | 10.61 |
| EV / EBIT | 14.63 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.38 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 3.58 |
| Debt / FCF | n/a |
| Interest Coverage | 1.86 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 4.59% |
| Return on Assets (ROA) | 4.15% |
| Return on Invested Capital (ROIC) | 7.47% |
| Return on Capital Employed (ROCE) | 7.91% |
| Weighted Average Cost of Capital (WACC) | 9.17% |
| Revenue Per Employee | $346,000 |
| Profits Per Employee | $8,840 |
| Employee Count | 2,500 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.76 |
Taxes
| Measure | Value |
|---|
| Income Tax | 5.20M |
| Effective Tax Rate | 18.77% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +53.33% |
| 50-Day Moving Average | 18.46 |
| 200-Day Moving Average | 13.60 |
| Relative Strength Index (RSI) | 59.70 |
| Average Volume (20 Days) | 567,394 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.63M |
| Short Previous Month | 1.65M |
| Short % of Shares Out | 3.87% |
| Short % of Float | 3.94% |
| Short Ratio (days to cover) | 3.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 865.00M |
| Gross Profit | 296.90M |
| Operating Income | 72.20M |
| Pretax Income | 27.70M |
| Net Income | 22.10M |
| EBITDA | 99.50M |
| EBIT | 72.20M |
| Earnings Per Share (EPS) | $0.52 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 100.10M |
| Total Debt | 379.30M |
| Net Cash | -279.20M |
| Net Cash Per Share | -$6.62 |
| Equity (Book Value) | 510.50M |
| Book Value Per Share | 11.78 |
| Working Capital | 445.70M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 11.30M |
| Capital Expenditures | -31.50M |
| Depreciation & Amortization | 27.30M |
| Net Borrowing | -24.00M |
| Free Cash Flow | -20.20M |
| FCF Per Share | -$0.48 |
Margins
| Measure | Value |
|---|
| Gross Margin | 34.32% |
| Operating Margin | 8.35% |
| Pretax Margin | 3.20% |
| Profit Margin | 2.55% |
| EBITDA Margin | 11.50% |
| EBIT Margin | 8.35% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.55% |
| Shareholder Yield | -2.55% |
| Earnings Yield | 2.82% |
| FCF Yield | -2.60% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $18.90 |
| Price Target Difference | 2.55% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 3.11% |
| EPS Growth Forecast (3Y) | 10.06% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |